• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

In Vitro Characterization of Solid Nano Particles containing Methotrexate and Doxycycline

    Deepa. N, Vignesh R, Swetha M D, Jegatheshwaran C, Jeevitha B K, Sharan Raj R, Sathya V, Vignesh K, Mathangi S, Karthikeyan S, Praveen Kumar B, Mohamed Musharaf B

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 10592-10596

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Rheumatoid arthritis is a chronic inflammatory illness that affects many elderly people's quality of life. Combinational DMARDs are a new therapeutic approach in managing disease conditions, based on the concept that the two medications work in two distinct routes to diminish (or) delay disease development.This study aimed to develop and improve the pharmacokinetic and safety margin of SLN as an MTX carrier in vitro. As a result, an attempt was made to construct SLN for the delivery of MTX and DOX and to evaluate size, stability, and drug release characteristics.Methods: supplied the methotrexate (Chennai, India). Micro Labs Pvt. Ltd provided the Doxycycline (Hosur, India). Tokyo Chemicals Industries provided the tristearin. Himedia Laboratories Pvt. Ltd provided stearic acid, Pluronic F68, Dialysis Membrane, and Membrane Filter (Mumbai, India).
SD fine chem. Lyophilization eliminates excess water from SLN and improves its storage stability. A calibration curve for the medicines MTX/DOX was created using standard solutions of MTX and DOX, each with final concentrations of 10, 20, 30, 40, and 50 g/mL. An experiment using a simple and sensitive spectrophotometric approach was used to determine the number of pharmaceuticals present in the SLN formulation.Both MTX and DOX were discovered to have higuchi first-order kinetics and Higuchi zero-order kinetics, respectively. The release was initially relatively low (up to 3 hours) since it takes time for the medications to diffuse out of the lipid matrix, suggesting a strong embodiment of pharmaceuticals in the lipid matrix and surrounding poloxamer coating & thickness (dependent on concentration). The release has become concentration-dependent as the MTX loaded in the SLN has decreased.Preliminary data show that the designed SLNs can administer dual medicines MTX and DOX without incompatibility. However, in vivo studies relevant to RA are required to validate their efficacy in vivo
Keywords:
  • PDF (131 K)
  • XML
(2022). In Vitro Characterization of Solid Nano Particles containing Methotrexate and Doxycycline. European Journal of Molecular & Clinical Medicine, 9(3), 10592-10596.
Deepa. N, Vignesh R, Swetha M D, Jegatheshwaran C, Jeevitha B K, Sharan Raj R, Sathya V, Vignesh K, Mathangi S, Karthikeyan S, Praveen Kumar B, Mohamed Musharaf B. "In Vitro Characterization of Solid Nano Particles containing Methotrexate and Doxycycline". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 10592-10596.
(2022). 'In Vitro Characterization of Solid Nano Particles containing Methotrexate and Doxycycline', European Journal of Molecular & Clinical Medicine, 9(3), pp. 10592-10596.
In Vitro Characterization of Solid Nano Particles containing Methotrexate and Doxycycline. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 10592-10596.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 45
  • PDF Download: 67
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus